{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:45:59Z","timestamp":1791773159431,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation (NRF) Competitive Program for rated Researchers","award":["SRUG2203301281"],"award-info":[{"award-number":["SRUG2203301281"]}]},{"name":"NRF Support for Y-rated researchers","award":["112244"],"award-info":[{"award-number":["112244"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02001-2","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:35:12Z","timestamp":1749058512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrated profiling of adiponectin and cytokine signaling pathways in high-fat diet-induced MASLD reveals early markers of disease progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Rabia","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samukelisiwe","family":"Shabalala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mabasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liske","family":"Kotz\u00e9-H\u00f6rstmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonhlakanipho","family":"Sangweni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritika","family":"Ramharack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pheiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afolake","family":"Arowolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han\u00e9l","family":"Sadie-Van Gijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"9","key":"2001_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7 (9), 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"2001_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"Makri, E., Goulas, A. & Polyzos, S. A. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch. Med. Res. 52 (1), 25\u201337 (2021).","journal-title":"Arch. Med. Res."},{"key":"2001_CR3","doi-asserted-by":"crossref","unstructured":"Pan, Z., Shiha, G., Esmat, G., M\u00e9ndez-S\u00e1nchez, N. & Eslam, M. MAFLD predicts cardiovascular disease risk better than MASLD. Liver Int. (2024).","DOI":"10.1111\/liv.15931"},{"key":"2001_CR4","doi-asserted-by":"publisher","first-page":"109199","DOI":"10.1016\/j.cbi.2020.109199","volume":"330","author":"C-Y Lian","year":"2020","unstructured":"Lian, C-Y., Zhai, Z-Z., Li, Z-F. & Wang, L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biol. Interact. 330, 109199 (2020).","journal-title":"Chemico-Biol. Interact."},{"issue":"1","key":"2001_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek, J. et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 8 (1), 20\u201330 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"21","key":"2001_CR6","doi-asserted-by":"publisher","first-page":"11905","DOI":"10.3390\/ijms222111905","volume":"22","author":"S Di Mauro","year":"2021","unstructured":"Di Mauro, S. et al. Clinical and molecular biomarkers for diagnosis and staging of NAFLD. Int. J. Mol. Sci. 22 (21), 11905 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"2001_CR7","doi-asserted-by":"publisher","first-page":"13087","DOI":"10.1074\/jbc.M800533200","volume":"283","author":"BN Reid","year":"2008","unstructured":"Reid, B. N. et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J. Biol. Chem. 283 (19), 13087\u201313099 (2008).","journal-title":"J. Biol. Chem."},{"key":"2001_CR8","doi-asserted-by":"publisher","first-page":"108065","DOI":"10.1016\/j.intimp.2021.108065","volume":"99","author":"H-J Liu","year":"2021","unstructured":"Liu, H-J. et al. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c\/SCD1 signaling pathway and modulating gut microbiota. Int. Immunopharmacol. 99, 108065 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"2001_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4162\/nrp.2013.7.4.294","volume":"7","author":"M-Y Park","year":"2013","unstructured":"Park, M-Y. & Mun, S. T. Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice. Nutr. Res. Pract. 7 (4), 294\u2013301 (2013).","journal-title":"Nutr. Res. Pract."},{"issue":"2","key":"2001_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","volume":"8","author":"ZV Wang","year":"2016","unstructured":"Wang, Z. V. & Scherer, P. E. Adiponectin, the past two decades. J. Mol. Cell Biol. 8 (2), 93\u2013100 (2016).","journal-title":"J. Mol. Cell Biol."},{"key":"2001_CR11","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front. Immunol. 13, 880298 (2022).","journal-title":"Front. Immunol."},{"key":"2001_CR12","doi-asserted-by":"crossref","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a Tale of Two Hits?  842\u2013845 (Elsevier, 1998).","DOI":"10.1016\/S0016-5085(98)70599-2"},{"issue":"11","key":"2001_CR13","doi-asserted-by":"publisher","first-page":"21240","DOI":"10.3390\/ijms141121240","volume":"14","author":"A Nakamura","year":"2013","unstructured":"Nakamura, A. & Terauchi, Y. Lessons from mouse models of high-fat diet-induced NAFLD. Int. J. Mol. Sci. 14 (11), 21240\u201321257 (2013).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2001_CR14","first-page":"984578","volume":"2015","author":"N Duarte","year":"2015","unstructured":"Duarte, N. et al. How inflammation impinges on NAFLD: a role for Kupffer cells. Biomed. Res. Int. 2015 (1), 984578 (2015).","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"2001_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/cancers13040730","volume":"13","author":"M Peiseler","year":"2021","unstructured":"Peiseler, M. & Tacke, F. Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma. Cancers 13 (4), 730 (2021).","journal-title":"Cancers"},{"issue":"4","key":"2001_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen, N., Crouchet, E. & Baumert, T. F. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 9 (4), 875 (2020).","journal-title":"Cells"},{"key":"2001_CR17","doi-asserted-by":"publisher","first-page":"904366","DOI":"10.3389\/fphys.2022.904366","volume":"13","author":"L Kotz\u00e9-H\u00f6rstmann","year":"2022","unstructured":"Kotz\u00e9-H\u00f6rstmann, L. et al. Characterization and comparison of the divergent metabolic consequences of high-sugar and high-fat diets in male Wistar rats. Front. Physiol. 13, 904366 (2022).","journal-title":"Front. Physiol."},{"issue":"24","key":"2001_CR18","doi-asserted-by":"publisher","first-page":"12648","DOI":"10.1039\/D2FO02440C","volume":"13","author":"L Kotz\u00e9-H\u00f6rstmann","year":"2022","unstructured":"Kotz\u00e9-H\u00f6rstmann, L., Bedada, D., Johnson, R., Mabasa, L. & Sadie-Van Gijsen, H. The effects of a green Rooibos (Aspalathus linearis) extract on metabolic parameters and adipose tissue biology in rats fed different obesogenic diets. Food Funct. 13 (24), 12648\u201312663 (2022).","journal-title":"Food Funct."},{"issue":"1","key":"2001_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Stanley, G. S. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1), 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"2001_CR20","doi-asserted-by":"crossref","unstructured":"Boehm, O. et al. Clinical chemistry reference database for Wistar rats and C57\/BL6 mice. (2007).","DOI":"10.1515\/BC.2007.161"},{"issue":"11","key":"2001_CR21","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","volume":"18","author":"R Kirsch","year":"2003","unstructured":"Kirsch, R. et al. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J. Gastroenterol. Hepatol. 18 (11), 1272\u20131282 (2003).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2001_CR22","doi-asserted-by":"publisher","first-page":"110785","DOI":"10.1016\/j.biopha.2020.110785","volume":"131","author":"SC Shabalala","year":"2020","unstructured":"Shabalala, S. C. et al. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed. Pharmacother. 131, 110785 (2020).","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"2001_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/medicina58060761","volume":"58","author":"N Nagata","year":"2022","unstructured":"Nagata, N., Chen, G., Xu, L. & Ando, H. An update on the chemokine system in the development of NAFLD. Medicina 58 (6), 761 (2022).","journal-title":"Medicina"},{"issue":"3","key":"2001_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra, F. & Tacke, F. Roles for chemokines in liver disease. Gastroenterology 147 (3), 577\u2013594 (2014). e1.","journal-title":"Gastroenterology"},{"issue":"58","key":"2001_CR25","doi-asserted-by":"publisher","first-page":"97965","DOI":"10.18632\/oncotarget.18967","volume":"8","author":"HH Nam","year":"2017","unstructured":"Nam, H. H. et al. Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization. Oncotarget 8 (58), 97965 (2017).","journal-title":"Oncotarget"},{"key":"2001_CR26","doi-asserted-by":"publisher","first-page":"175628481881518","DOI":"10.1177\/1756284818815184","volume":"11","author":"W Chen","year":"2018","unstructured":"Chen, W., Zhang, J., Fan, H-N. & Zhu, J-S. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. Therapeutic Adv. Gastroenterol. 11, 1756284818815184 (2018).","journal-title":"Therapeutic Adv. Gastroenterol."},{"key":"2001_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2021.03.005","volume":"134","author":"J Li","year":"2021","unstructured":"Li, J. et al. IFN-\u03b3 contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1\u03b2\/TLR2 signaling pathway. Mol. Immunol. 134, 118\u2013128 (2021).","journal-title":"Mol. Immunol."},{"issue":"4","key":"2001_CR28","first-page":"327","volume":"16","author":"A Hadinia","year":"2019","unstructured":"Hadinia, A., Doustimotlagh, A. H., Goodarzi, H. R., Arya, A. & Jafarinia, M. Circulating levels of pro-inflammatory cytokines in patients with nonalcoholic fatty liver disease and non-alcoholic steatohepatitis. Iran. J. Immunol. 16 (4), 327\u2013333 (2019).","journal-title":"Iran. J. Immunol."},{"issue":"3","key":"2001_CR29","first-page":"244","volume":"36","author":"J Kountouras","year":"2023","unstructured":"Kountouras, J. et al. Innate immunity and nonalcoholic fatty liver disease. Annals Gastroenterol. 36 (3), 244 (2023).","journal-title":"Annals Gastroenterol."},{"issue":"1","key":"2001_CR30","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1002\/imt2.76","volume":"2","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease. Imeta 2 (1), e76 (2023).","journal-title":"Imeta"},{"issue":"1","key":"2001_CR31","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1038\/s41467-024-49633-y","volume":"15","author":"RH Friedline","year":"2024","unstructured":"Friedline, R. H. et al. IFN\u03b3-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease. Nat. Commun. 15 (1), 5506 (2024).","journal-title":"Nat. Commun."},{"issue":"9","key":"2001_CR32","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/biomedicines12092144","volume":"12","author":"S-C Coste","year":"2024","unstructured":"Coste, S-C. et al. Metabolic Dysfunction-Associated steatotic liver disease: the associations between inflammatory markers, TLR4, and cytokines IL-17A\/F, and their connections to the degree of steatosis and the risk of fibrosis. Biomedicines 12 (9), 2144 (2024).","journal-title":"Biomedicines"},{"key":"2001_CR33","doi-asserted-by":"crossref","unstructured":"Yu, T. et al. Gut Microbiota\u2013NLRP3 inflammasome crosstalk in metabolic dysfunction-associated steatotic liver disease. Clin. Res. Hepatol. Gastroenterol.  102458. (2024).","DOI":"10.1016\/j.clinre.2024.102458"},{"key":"2001_CR34","doi-asserted-by":"crossref","unstructured":"Ullah, A., Singla, R. K., Batool, Z., Cao, D. & Shen, B. Pro-and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases). Rev.  Endocr. Metab. Disord.  1\u201321. (2024).","DOI":"10.1007\/s11154-024-09884-y"},{"key":"2001_CR35","doi-asserted-by":"publisher","first-page":"149671","DOI":"10.1016\/j.bbrc.2024.149671","volume":"703","author":"W Cho","year":"2024","unstructured":"Cho, W. et al. Interleukin-27 as a novel player in alleviating hepatic steatosis: mechanistic insights from an in vitro analysis. Biochem. Biophys. Res. Commun. 703, 149671 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2001_CR36","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s10620-015-3614-z","volume":"60","author":"N Alkhouri","year":"2015","unstructured":"Alkhouri, N. et al. Circulating soluble Fas and Fas ligand levels are elevated in children with nonalcoholic steatohepatitis. Dig. Dis. Sci. 60, 2353\u20132359 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"2001_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","volume":"59","author":"S Thapaliya","year":"2014","unstructured":"Thapaliya, S. et al. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model. Dig. Dis. Sci. 59, 1197\u20131206 (2014).","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"2001_CR38","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2337\/db07-0156","volume":"56","author":"J Westerbacka","year":"2007","unstructured":"Westerbacka, J. et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56 (11), 2759\u20132765 (2007).","journal-title":"Diabetes"},{"key":"2001_CR39","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren, J. & Scheja, L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol. Metabolism. 50, 101238 (2021).","journal-title":"Mol. Metabolism"},{"issue":"1","key":"2001_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3892\/mmr.2023.13138","volume":"29","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Transcriptomics reveal a molecular signature in the progression of nonalcoholic steatohepatitis and identifies PAI\u20131 and MMP\u20139 as biomarkers in in vivo and in vitro studies. Mol. Med. Rep. 29 (1), 15 (2023).","journal-title":"Mol. Med. Rep."},{"key":"2001_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-017-0572-9","volume":"16","author":"Z Chen","year":"2017","unstructured":"Chen, Z., Yu, R., Xiong, Y., Du, F. & Zhu, S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 16, 1\u20139 (2017).","journal-title":"Lipids Health Dis."},{"issue":"16","key":"2001_CR42","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.3390\/ijms241612748","volume":"24","author":"M Vitulo","year":"2023","unstructured":"Vitulo, M. et al. Current therapeutical approaches targeting lipid metabolism in NAFLD. Int. J. Mol. Sci. 24 (16), 12748 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"2001_CR43","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.3390\/ijms241612665","volume":"24","author":"A Tsay","year":"2023","unstructured":"Tsay, A. & Wang, J-C. The role of PIK3R1 in metabolic function and insulin sensitivity. Int. J. Mol. Sci. 24 (16), 12665 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"2001_CR44","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt, A. & Al-Hasani, H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pfl\u00fcgers Archiv-European J. Physiol. 472 (9), 1273\u20131298 (2020).","journal-title":"Pfl\u00fcgers Archiv-European J. Physiol."},{"issue":"4","key":"2001_CR45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.beem.2007.08.004","volume":"21","author":"S Koren","year":"2007","unstructured":"Koren, S. & Fantus, I. G. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract. Res. Clin. Endocrinol. Metab. 21 (4), 621\u2013640 (2007).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2001_CR46","doi-asserted-by":"crossref","unstructured":"Nogueira-Ferreira, R., Oliveira, P. F. & Ferreira, R. Liver Metabolism: the Pathways Underlying Glucose Utilization and Production  141\u2013156 (Elsevier, 2024).","DOI":"10.1016\/B978-0-323-91704-9.00018-5"},{"issue":"11","key":"2001_CR47","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovi\u0107","year":"2023","unstructured":"Veskovi\u0107, M. et al. The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease\u2014the transition from an adipocentric to liver-centric approach. Curr. Issues. Mol. Biol. 45 (11), 9084\u20139102 (2023).","journal-title":"Curr. Issues. Mol. Biol."},{"issue":"10","key":"2001_CR48","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/antiox10101546","volume":"10","author":"Y Son","year":"2021","unstructured":"Son, Y. et al. Ameliorative effect of Annona muricata (Graviola) extract on hyperglycemia induced hepatic damage in type 2 diabetic mice. Antioxidants 10 (10), 1546 (2021).","journal-title":"Antioxidants"},{"issue":"13","key":"2001_CR49","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.3390\/ijms22136777","volume":"22","author":"SY Neshat","year":"2021","unstructured":"Neshat, S. Y., Quiroz, V. M., Wang, Y., Tamayo, S. & Doloff, J. C. Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions. Int. J. Mol. Sci. 22 (13), 6777 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"2001_CR50","doi-asserted-by":"publisher","first-page":"956","DOI":"10.21037\/hbsn-23-548","volume":"12","author":"R Manikat","year":"2023","unstructured":"Manikat, R., Ahmed, A. & Kim, D. Up-to-date global epidemiology of nonalcoholic fatty liver disease. Hepatobiliary Surg. Nutr. 12 (6), 956 (2023).","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"5","key":"2001_CR51","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/nu13051442","volume":"13","author":"P Vancells Lujan","year":"2021","unstructured":"Vancells Lujan, P., Vinas Esmel, E. & Sacanella Meseguer, E. Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients 13 (5), 1442 (2021).","journal-title":"Nutrients"},{"key":"2001_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10620-009-0815-3","volume":"55","author":"Z-J Xu","year":"2010","unstructured":"Xu, Z-J., Fan, J-G., Ding, X-D., Qiao, L. & Wang, G-L. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig. Dis. Sci. 55, 931\u2013940 (2010).","journal-title":"Dig. Dis. Sci."},{"key":"2001_CR53","doi-asserted-by":"publisher","first-page":"176800","DOI":"10.1016\/j.ejphar.2024.176800","volume":"978","author":"S Khatoon","year":"2024","unstructured":"Khatoon, S. et al. Apigenin-6-C-glucoside ameliorates MASLD in rodent models via selective agonism of adiponectin receptor 2. Eur. J. Pharmacol. 978, 176800 (2024).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"2001_CR54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.10.042","volume":"80","author":"WP Esler","year":"2024","unstructured":"Esler, W. P. & Cohen, D. E. Pharmacologic Inhibition of lipogenesis for the treatment of NAFLD. J. Hepatol. 80 (2), 362\u2013377 (2024).","journal-title":"J. Hepatol."},{"issue":"2","key":"2001_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/biomedicines6020052","volume":"6","author":"T Gamberi","year":"2018","unstructured":"Gamberi, T., Magherini, F., Modesti, A. & Fiaschi, T. Adiponectin signaling pathways in liver diseases. Biomedicines 6 (2), 52 (2018).","journal-title":"Biomedicines"},{"issue":"1","key":"2001_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel, V. T. & Shulman, G. I. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J. Clin. Investig. 126 (1), 12\u201322 (2016).","journal-title":"J. Clin. Investig."},{"issue":"10","key":"2001_CR57","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1210\/mend.15.10.0711","volume":"15","author":"LV Ravichandran","year":"2001","unstructured":"Ravichandran, L. V., Chen, H., Li, Y. & Quon, M. J. Phosphorylation of PTP1B at Ser50 by Akt impairs its ability to dephosphorylate the insulin receptor. Mol. Endocrinol. 15 (10), 1768\u20131780 (2001).","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"2001_CR58","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2337\/db08-0913","volume":"58","author":"M Delibegovic","year":"2009","unstructured":"Delibegovic, M. et al. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced Endoplasmic reticulum stress. Diabetes 58 (3), 590\u2013599 (2009).","journal-title":"Diabetes"},{"issue":"1","key":"2001_CR59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/ph16010106","volume":"16","author":"J Li","year":"2023","unstructured":"Li, J. et al. CX08005, a protein tyrosine phosphatase 1b inhibitor, attenuated hepatic lipid accumulation and microcirculation dysfunction associated with nonalcoholic fatty liver disease. Pharmaceuticals 16 (1), 106 (2023).","journal-title":"Pharmaceuticals"},{"issue":"13","key":"2001_CR60","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.3390\/ijms25137207","volume":"25","author":"NE Read","year":"2024","unstructured":"Read, N. E. & Wilson, H. M. Recent developments in the role of protein tyrosine phosphatase 1B (PTP1B) as a regulator of immune cell signalling in health and disease. Int. J. Mol. Sci. 25 (13), 7207 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"2001_CR61","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2013.12.026","volume":"60","author":"A Eguchi","year":"2014","unstructured":"Eguchi, A., Wree, A. & Feldstein, A. E. Biomarkers of liver cell death. J. Hepatol. 60 (5), 1063\u20131074 (2014).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02001-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:03:55Z","timestamp":1749063835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02001-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2001"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02001-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental methods were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institute of Health (NIH, 8th Edition, 2011), the Animal Research: Reporting of In vivo Experiments (ARRIVE) guidelines, which were approved by the Animal Research Ethics Committees at Stellenbosch University (SU-ACU-2018-6786) and the University of Zululand (PGD2017\/206).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read, reviewed and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"19700"}}